- Home
- BKU vs SNY Comparison
BKU vs SNY Comparison
Compare BKU & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- SNY
- Stock Information
- Founded
- BKU 2009
- SNY 1994
- Country
- BKU United States
- SNY France
- Employees
- BKU N/A
- SNY N/A
- Industry
- BKU Savings Institutions
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- SNY Health Care
- Exchange
- BKU Nasdaq
- SNY Nasdaq
- Market Cap
- BKU 2.8B
- SNY 113.4B
- IPO Year
- BKU 2011
- SNY N/A
- Fundamental
- Price
- BKU $37.84
- SNY $47.02
- Analyst Decision
- BKU Hold
- SNY Buy
- Analyst Count
- BKU 11
- SNY 4
- Target Price
- BKU $41.82
- SNY $61.50
- AVG Volume (30 Days)
- BKU 555.4K
- SNY 2.8M
- Earning Date
- BKU 10-21-2025
- SNY 10-24-2025
- Dividend Yield
- BKU 3.15%
- SNY 3.43%
- EPS Growth
- BKU 51.05
- SNY 118.56
- EPS
- BKU 3.41
- SNY 8.65
- Revenue
- BKU $999,760,000.00
- SNY $53,714,621,258.00
- Revenue This Year
- BKU $15.20
- SNY $1.53
- Revenue Next Year
- BKU $6.43
- SNY $7.06
- P/E Ratio
- BKU $11.54
- SNY $5.39
- Revenue Growth
- BKU 13.39
- SNY 15.65
- 52 Week Low
- BKU $28.21
- SNY $44.73
- 52 Week High
- BKU $44.45
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- BKU 46.12
- SNY 42.69
- Support Level
- BKU $38.44
- SNY $46.79
- Resistance Level
- BKU $39.59
- SNY $47.69
- Average True Range (ATR)
- BKU 0.82
- SNY 0.66
- MACD
- BKU -0.14
- SNY -0.22
- Stochastic Oscillator
- BKU 18.24
- SNY 34.09
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.